Table 6.
Sr. No. | Compound | Structure | % Inhibition/IC50 | Ref. |
---|---|---|---|---|
31. | (E)-1-(furan-3-yl)-3-(1H-indol-3-yl) prop2-en-1-one | 87.67% | (Ramesh et al., 2020) | |
32. | 2-(Indol-3-yl)-2-oxo-acetamide | 0.9 μg/mL | (Mashayekhi et al., 2021) | |
33. | 3-(1H-indol-3-yl) propanoic acid | 68 μM | (Negatu et al., 2018) | |
34. | Hybrid hydrazides and hydrazide-hydrazones indoles | 0.2 μg/mL | (Velezheva et al., 2016) | |
35. | Indole-benzimidazole-based 1,2,3-triazole hybrids | 3.125–6.25 μg/mL |
(Ashok et al., 2018) | |
36. | Indole-based thiosemicarbazones | 1.9 μg/mL | (Mashayekhi et al., 2021) | |
37. | Indole diketo acids | 0.02 μM | (Libardo et al., 2018) |